Evofem Biosciences, Inc. (EVFM)
OID · Healthcare · Biotechnology
$0.01
-3.75%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.0M
Shares Outstanding
132.5M
P/S (TTM)
0.1x
Exchange
OID
Currency
USD
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 5.0M | 9.6M | 899K | 2.6M |
| Gross Profit | 4.0M | 7.0M | 489K | |
| Operating Income | (982K) | 3.3M | (4.6M) | (2.5M) |
| Net Income | (1.6M) | 2.8M | (5.5M) | (11.0M) |
| Diluted EPS | $-0.01 | N/A | $-0.04 | N/A |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 16.8M | 18.2M | 19.4M | 20.2M |
| Gross Profit | 12.4M | 11.7M | 15.5M | 15.6M |
| Operating Income | (84.1M) | (17.8M) | (7.7M) | 1.4M |
| Net Income | (76.7M) | 53.0M | (8.9M) | 391K |
| Diluted EPS | $-167.50 | $0.05 | $-0.12 | $0.00 |